Eqis Capital Management, Inc. Vertex Pharmaceuticals Inc Transaction History
Eqis Capital Management, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Eqis Capital Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 4,755 shares of VRTX stock, worth $2.28 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,755
Previous 4,714
0.87%
Holding current value
$2.28 Million
Previous $2.19 Million
12.68%
% of portfolio
0.17%
Previous 0.18%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,754Shares Held
227MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.6 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.1 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.2 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.74 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $123B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...